Indication
Proparacaine Hydrochloride sterile eye drops is indicated for procedures in which a topical ophthalmic anesthetic is indicated: corneal anesthesia of short duration, e.g., tonometry, gonioscopy, removal of corneal foreign bodies, and for short corneal and conjunctival procedures.
Dosage & Administration
Deep anesthesia as in cataract extraction: Instill 1 drop to the eye every 5 to 10 minutes for 5 to 7 doses.
Removal of sutures: Instill 1 or 2 drops to the eye 2 or 3 minutes before removal of stitches.
Removal of foreign bodies: Instill 1 or 2 drops to the eye prior to operating.
Tonometry: Instill 1 or 2 drops to the eye immediately before measurement.
Precautions
Prolonged use of a topical ocular anesthetic is not recommended. It may produce permanent corneal opacification with accompanying visual loss.
Special Precautions
Pregnancy: Category C
Animal reproduction studies have not been conducted with Proparacaine Hydrochloride sterile eye drops 0.5%. It is also not known whether Proparacaine Hydrochloride can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Proparacaine Hydrochloride should be administered to a pregnant woman only if clearly needed.
Nursing Mothers:
It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Proparacaine Hydrochloride is administered to a nursing mother.
Pediatric Use:
Safety and effectiveness of Proparacaine Hydrochloride sterile eye drops in pediatric patients have been established. Use of Proparacaine Hydrochloride is supported by evidence from adequate and well-controlled studies in adults and children over the age of twelve, and safety information in neonates and other pediatric patients.
Geriatric Use:
No overall clinical differences in safety or effectiveness have been observed between the elderly and other adult patients.
